Khalil G. Saikali - Concepedia

Concepedia

Author

Khalil G. Saikali

Cytokinetics (United States)

Also Known As

C. Sun, K SAIKALI, K Saikali, K. Saikali, K.G. Saikali, KHALIL SAIKALI, Khalil G Saikali, Khalil G. Saikali, Khalil Saikali

57

Publications

2.6K

Citations

19

H-Index

76

Concepts

All Affiliations

Cytokinetics (United States)FibroGen (United States)San Francisco VA Medical Center Kidney Associates Federal Almazov North-West Medical Research Centre

KG

About

Khalil G. Saikali is an author at Cytokinetics (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.4K
2	Health Sciences	3	3	209
3	Engineering	1	1	13
4	Public Health	1	1	260
5	Social Sciences	1	1	209

Khalil G. Saikali

×

23

Publications

2.6K

Citations

19

H-Index

	Year	Citations
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial John G.F. Cleland, John R. Teerlink, Roxy Senior, The Lancet CardiomyopathyHeart FailureOmecamtiv MecarbilCardiovascular DiseaseSystolic Heart Failure	2011	329
Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD Robert Provenzano, Anatole Besarab, Chao Sun, Clinical Journal of the American Society of Nephrology	2016	290
Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study John R. Teerlink, Cyril P. Clarke, Khalil G. Saikali, The Lancet Cardiac MuscleCardiomyopathyOmecamtiv MecarbilCardiovascular DiseaseCardiac Mechanic	2011	260
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study Robert Provenzano, Anatole Besarab, Steven Charles Wright, American Journal of Kidney Diseases	2016	254
Roxadustat (FG-4592) Anatole Besarab, Igor Motylev, Evgeny Shutov, Journal of the American Society of Nephrology AnemiaHemodialysisUrologyHeme HomeostasisIron Metabolism	2015	246
A Double-Blind, Randomized, Placebo-Controlled Trial of Escitalopram in the Treatment of Pediatric Depression Karen Dineen Wagner, Jeffrey M. Jonas, Robert L. Findling, Journal of the American Academy of Child & Adolescent Psychiatry PsychiatryMedicinePsychotropic MedicationPediatricsPsychopharmacology	2006	209
Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases Alan J. Russell, James J. Hartman, Aaron C. Hinken, Nature Medicine MechanobiologyMuscle FunctionMuscle InjurySkeletal MuscleMedicine	2012	136
Tadalafil has No Detrimental Effect on Human Spermatogenesis or Reproductive Hormones Wayne J.G. Hellstrom, James W. Overstreet, Albert S. Yu, The Journal of Urology	2003	131
Roxadustat for CKD-related Anemia in Non-dialysis Patients Daniel W. Coyne, Simon D. Roger, Sug Kyun Shin, Kidney International Reports	2020	107
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study Chaim Charytan, Roberto Manllo-Karim, Edouard Martin, Kidney International Reports	2021	96

Page 1